Professors Niren Murthy and Irina Conboy are lead authors on a new study which demonstrates the delivery of CRISPR genome-editing molecules via nanoparticles rather than via viruses. They show that CRISPR components can be packaged around individual gold nanoparticles and wrapped in a protecting polymer, and that the nanoparticles deliver the CRISPR components into a wide variety of cells efficiently.
Prof Irina Conboy’s lab has pioneered a method that paves the way to characterization of proteome alterations in vivo, whether imposed by age or disease.This research was published in Nature Communications.
Professor Amy Herr’s lab has been awarded an R33 grant as part of the 2017 Beau Biden Cancer Moonshot Initiative. The grant will fund their work on “Advanced Cancer Classification via Single-Cell Electrophoretic Cytopathology.”
The National Cancer Moonshot works to accelerate research efforts by enhancing data access and facilitating collaborations among researchers, doctors, philanthropies, patients, patient advocates, and biotechnology and pharmaceutical companies. The initiative aims to bring about a decade’s worth of advances in five years.
Bioengineering tops the new Forbes’ Best And Worst Master’s Degrees For Jobs In 2017 list! PayScale’s analysis shows that, among those with biomedical engineering master’s degrees, compensation leaps from $70,200 at the early-career stage to $129,300 by mid-career. These graduates also go on to derive high satisfaction and meaning from their jobs.
MTM alumnus Michael Hemati, Senior R&D Engineer at Theranova, has been named one of Medtech’s Rising Stars of 2017. Hematic is currently heading medical device startups Leo Labs and TruKinetics, and was one of the founders of SmartDerm, a startup founded from an MTM project.
BioE keeps climbing — our undergraduate program has moved up another notch in the annual US News & World Report ranking to #7 in the nation!
Investor, Reach Capital
B.S. Bioengineering, Minor IEOR, 2009
MBA Wharton, 2015, MPA Harvard Kennedy School, 2016
I’m an early-stage investor in education technology companies. I spend my time meeting with entrepreneurs, evaluating potential investments, and supporting our portfolio companies with everything from recruiting to product strategy.
“I’m very thankful for the analytical and problem solving skills that were an integral part of the Bioengineering program. One specific course that deeply shaped my career was the Capstone course with Professor Amy Herr.”
Research Associate, Protein Fluidics, Inc.
BS Bioengineering, 2016
My role is to provide an interface between the different realms that need to be crossed to take our device to market, namely the biochemistry and the microfluidics.
“Berkeley Bioengineering enabled me, through hands-on research experience and by being able to take classes across different departments, to create a balanced profile, something critical for being constructive in a small start-up.”
Gary Chan, Albert Lan, Kathleen Lo, Tiffany Truong
The Capstone team introduced a device that allows for constant drainage of a hemothorax in trauma patients requiring a thoracostomy.